Rx Bandz Inc., Austin, Texas, was awarded a $10,732,410 cost-plus-fixed-fee contract for a tactical injection kit. This contract provides for the development of an FDA-approved auto-injector device that can deliver a pre-measured dose of hydromorphone for mild sedation at point of injury in austere environments and/or during patient transport. Work will be performed in Fairfield, New Jersey, and is expected to be completed by Oct. 1, 2029. This contract was a sole source acquisition. Fiscal 2023 research, development, test and evaluation funds in the amount of $1,241,173 are being obligated at time of award. The Air Force Research Laboratory Wright Research Site, Wright-Patterson Air Force Base, Ohio, is the contracting activity (FA2384-24-C-B014).